End to end Closed Systems CAR T Production: Translating PD to Commercial Manufacturing
Topics
ACTRIS Signature Workshop Series
15 September 2025
Join us to learn about scaling CAR-T therapy from process development to commercial manufacturing.
Registration is now closed.
We are delighted to present the next ๐๐๐ง๐ฅ๐๐ฆ ๐ฆ๐ถ๐ด๐ป๐ฎ๐๐๐ฟ๐ฒ ๐ช๐ผ๐ฟ๐ธ๐๐ต๐ผ๐ฝ ๐ฎ๐ฌ๐ฎ๐ฑ in partnership with Thermo Fisher Scientific (opens in new tab) - ๐๐ป๐ฑ-๐๐ผ-๐ฒ๐ป๐ฑ ๐๐น๐ผ๐๐ฒ๐ฑ ๐ฆ๐๐๐๐ฒ๐บ๐ ๐๐๐ฅ-๐ง ๐ฃ๐ฟ๐ผ๐ฑ๐๐ฐ๐๐ถ๐ผ๐ป: ๐ง๐ฟ๐ฎ๐ป๐๐น๐ฎ๐๐ถ๐ป๐ด ๐ณ๐ฟ๐ผ๐บ ๐ฃ๐ฟ๐ผ๐ฐ๐ฒ๐๐ ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐ ๐๐ผ ๐๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ถ๐ฎ๐น ๐ ๐ฎ๐ป๐๐ณ๐ฎ๐ฐ๐๐๐ฟ๐ถ๐ป๐ด.
This workshop offers a full journey through the end-to-end (E2E) closed systems approach, equipping you with the insights needed to scale CAR-T cell therapy safely and efficiently.
๐
๐๐ฎ๐๐ฒ: Friday, 31 October 2025
๐ ๐ง๐ถ๐บ๐ฒ: 9:00 AM โ 5:00 PM
๐ ๐ฉ๐ฒ๐ป๐๐ฒ: ACTRIS Facility, 30 Hospital Boulevard, #19-02, Singapore 168583
๐ฒย ๐ฅ๐ฒ๐ด๐ถ๐๐๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐๐ฒ๐ฒ:ย SGD $100 (excluding GST)
๐ย ๐ฅ๐ฒ๐ด๐ถ๐๐๐ฒ๐ฟ ๐ต๐ฒ๐ฟ๐ฒ: https://lnkd.in/gTxHVih9 (opens in new tab)
๐๐ข๐บ๐ฎ๐ฆ๐ฏ๐ต ๐๐ ๐ค๐ฐ๐ฅ๐ฆ ๐ธ๐ช๐ญ๐ญ ๐ฃ๐ฆ ๐ด๐ฆ๐ฏ๐ต ๐ต๐ฐ ๐บ๐ฐ๐ถ๐ณ ๐ณ๐ฆ๐จ๐ช๐ด๐ต๐ฆ๐ณ๐ฆ๐ฅ ๐ฆ-๐ฎ๐ข๐ช๐ญ. ๐๐ฆ๐จ๐ช๐ด๐ต๐ณ๐ข๐ต๐ช๐ฐ๐ฏ ๐ช๐ด ๐ค๐ฐ๐ฏ๐ง๐ช๐ณ๐ฎ๐ฆ๐ฅ ๐ถ๐ฑ๐ฐ๐ฏ ๐ฑ๐ข๐บ๐ฎ๐ฆ๐ฏ๐ต.
๐ง๐ฟ๐ฎ๐ถ๐ป๐ฒ๐ฟ๐:
โข Ryan Lim (opens in new tab) (PhD), Regional Sales Manager, Cell, Gene & Advanced Therapy, Asia Pacific and Japan, Thermo Fisher Scientific
โข Poh Loong SOONG (opens in new tab) (PhD), Field Application Scientist Team Lead, ๏ปฟCell, Gene & Advance Therapy, Thermo Fisher Scientific
๐ฏ ๐ช๐ต๐ผ ๐๐ต๐ผ๐๐น๐ฑ ๐ฎ๐๐๐ฒ๐ป๐ฑ:
Cell Therapy Researchers and Scientists, Process Development Scientists, Manufacturing Specialists, Quality Assurance Professionals, Regulatory Affairs Professionals.
โณ ๐ฅ๐ฒ๐ด๐ถ๐๐๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐ฐ๐น๐ผ๐๐ฒ๐ ๐๐ฟ๐ถ๐ฑ๐ฎ๐, ๐ญ๐ฌ ๐ข๐ฐ๐๐ผ๐ฏ๐ฒ๐ฟ ๐ฎ๐ฌ๐ฎ๐ฑ
Limited slots are available and will be allocated on a first-come, first-served basis upon completion of payment.